Join the club for FREE to access the whole archive and other member benefits.

Nano Precision Medical

Biopharmaceutical company with varied pipeline. Merger planned with Second Sight 2022.

Nano Precision Medical. Inc is a privately held biopharmaceutical company developing drug implants by leveraging the company’s proprietary NanoPortal drug implant technology. These drug implants, designed to deliver minimally fluctuating drug profiles, will address drug non-adherence which is one of the top reasons for sub-optimal clinical benefit associated with oral and injectable products that treat chronic disease.

The company’s lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes.

The Company’s headquarters are in Emeryville, California. 

Visit website:


Details last updated 18-Feb-2022

Nano Precision Medical News

Lights go off for people with obsolete Second Sight retinal implants

BBC - 17-Feb-2022

No promised upgrades, and no vision at all for some recipients

Topics mentioned on this page:
Vision (augmentation)